But it’s still not a long.


Kimberly Clark reported $1.44 adjusted EPS this morning versus consensus of $1.40. The better-than-expected results were driven by organic sales growth of 5%, which is being well-received by the market. Management raised the lower end of its FY13 guidance range to $5.65-5.75 versus $5.60-5.75 prior. Strong organic sales numbers took us by surprise; we see no reason to be involved in KMB at this stage.




We have been bearish on Kimberly Clark since mid-July and, while the stock has underperformed, the recent performance strength and strong organic growth numbers reported by the company have weakened our conviction in shorting the stock here, in a pair with EL (as we proposed) or otherwise.


Contrary to our prior expectations, KMB will likely meet the Street’s FY13 EPS expectations as top line performance has accelerated into 2H13, despite some industry data previously suggesting that this could be a tall task. Dollar weakness is certainly helping and will be worth monitoring going forward.




  • EBIT growth is being driven by cost savings alone as revenue growth remains anemic. The market may be unwilling to pay an above-average multiple for peer-lagging revenue and earnings growth.
  • We believe that input costs are worth monitoring over the remainder of the year as management’s guidance may be underestimating costs in 4Q13.

KMB DE-SHEETS OUR BEAR CASE - kmb cost savings chart


What we liked in 3Q13 Results:

  • EPS beat, supported by organic sales growth of 5%
  • Mgmt raised the low end of the guidance range by 5 cents
  • Strong KC-International organic sales of 10% boosted by emerging markets (China, Russia, to a lesser extent Brazil) accelerating
  • Sustained strong volume growth in emerging markets
  • Operating cash flow aided by improved working capital efficiency


What we didn’t like in 3Q13 Results:

  • EBIT growth decelerating further to 1% despite easier comp
  • No Operating Margin expansion year-over-year
  • Personal care operating margins declining 20bps
  • Organic growth in Europe being boosted by phasing out of weak businesses
  • Negative 3Q FCF growth (-0.5%) with EBIT growth slowing to +0.9% from +5.8% in 2Q13 despite management expecting cash flow generation to improve in 2H13 as of 7/22


Quantitative Levels

From a quantitative perspective, KMB has broken out above its intermediate-term TREND line of $98.24.





Rory Green

Senior Analyst






Premium insight

[UNLOCKED] Today's Daily Trading Ranges

“If I could only have one thing of the many things we have it would be my daily ranges." Hedgeye CEO Keith McCullough said recently.

read more

Cartoon of the Day: 'Biggest Tax Cut Ever'

President Donald Trump's economic team unveiled what he called last week, "the biggest tax cut we’ve ever had.” Before you get too excited about that hang on a sec. "Trump Tax Reform ain’t gettin’ done anytime soon," Hedgeye CEO Keith McCullough wrote in today's Early Look.

read more

Neurofinance: The Psychology Behind When To Sell A Bull Market

"Most momentum investors stay invested too long, under-reacting and holding tight after truly bad news finally arrives to break the trend," writes MarketPsych's Richard Peterson.

read more

Energy Stocks: Time to Buy the Dip? | $XLE

What the heck is happening in the Energy sector (XLE)? Energy stocks have trailed the S&P 500 by a whopping 15% in 2017. Before you buy the dip, here's what you need to know.

read more

Cartoon of the Day: Hard-Headed Bears

How's this for "hard data"? So far, 107 of 497 S&P 500 companies have reported aggregate sales and earnings growth of 4.4% and 13.2% respectively.

read more

Premium insight

McCullough [Uncensored]: When People Say ‘Everyone is Bullish, That’s Bulls@#t’

“You wonder why the performance of the hedge fund indices is so horrendous,” says Hedgeye CEO Keith McCullough, “they’re all doing the same thing, after the market moves. You shouldn’t be paid for that.”

read more

SECTOR SPOTLIGHT Replay | Healthcare Analyst Tom Tobin Today at 2:30PM ET

Tune in to this edition of Sector Spotlight with Healthcare analyst Tom Tobin and Healthcare Policy analyst Emily Evans.

read more

Ouchy!! Wall Street Consensus Hit By Epic Short Squeeze

In the latest example of what not to do with your portfolio, we have Wall Street consensus positioning...

read more

Cartoon of the Day: Bulls Leading the People

Investors rejoiced as centrist Emmanuel Macron edged out far-right Marine Le Pen in France's election day voting. European equities were up as much as 4.7% on the news.

read more

McCullough: ‘This Crazy Stat Drives Stock Market Bears Nuts’

If you’re short the stock market today, and your boss asks why is the Nasdaq at an all-time high, here’s the only honest answer: So far, Nasdaq company earnings are up 46% year-over-year.

read more

Who's Right? The Stock Market or the Bond Market?

"As I see it, bonds look like they have further to fall, while stocks look tenuous at these levels," writes Peter Atwater, founder of Financial Insyghts.

read more